Tralokinumab Treatment In Patients With Atopic Dermatitis and Moderate-to-Severe Hand Involvement: Results From the 32-week Phase 3b ADHAND Trial

20260 citationsJournal Articlediamond Open Access

Authors

N/A

Good health and well-being

Published in: SKIN The Journal of Cutaneous Medicine

Volume 10, Issue 2, pp. s744-s744

Field-Weighted Citation Impact: 0.00